Register entry
IMPAX LABORATORIES LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 152
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
152| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8377474 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 8454998 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 8557283 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 9089607 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 9089608 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 9463246 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 9533046 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 9901640 | RYTARYcarbidopa; levodopa | product | Dec 2028 |
| 10098845 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 10292935 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 10688058 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 10973769 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 10987313 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 11357733 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 11622941 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 11666538 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12064521 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12128141 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12178918 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12178919 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12274793 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12303605 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12403099 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12491164 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 12691074 | CREXONTcarbidopa; levodopa | product | Oct 2034 |
| 11986449 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12109185 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12194150 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12201596 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12263148 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12263149 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12295931 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12303481 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12303482 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12370163 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12447139 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12453710 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| 12458616 | CREXONTcarbidopa; levodopa | use | Dec 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| CREXONTCARBIDOPA; LEVODOPA | NP New product | Aug 2027 |
Enquiry
Common questions
- Is IMPAX LABORATORIES LLC FDA approved?
- IMPAX LABORATORIES LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.